EMA’s Heralded Revamp May Be Hampered By Tight Budget And Staffing
Executive Summary
The EMA has announced a major restructuring plan to better aid its stakeholders, but tight staffing levels and budget stagnation could hamper the effort.
You may also be interested in...
European Notebook: A Smooth Succession At Roche, EMA’s New Leadership Team, A Medicine Bank In Greece, Atorvastatin Price Drop In Ireland
Lufthansa's Christoph Franz will become Roche’s chairman next year; more restructuring details emerge from the European Medicines Agency; pharma companies donate medicines in Greece; Ireland names preferred medicines and aims to cut atorvastatin price.
European Regulatory Round Up: While EMA Opens Up, European Pharma Battens Down For Tough Year
The European Medicines Agency is focusing on transparency and pharmacovigilance over the next year, while the pharmaceutical industry is gearing up for a fight against austerity measures.
EMA Director-Nominee Guido Rasi Brings Track Record For Repairing Regulatory Agency Reputation
Rasi leads the Italian Medicines Agency, an agency also known for conditional reimbursement agreements.